Our Vision
Eliminating death and suffering from prostate cancer. We will achieve this through offering peer support to men who have been diagnosed with prostate cancer (and their families); actively promoting awareness of this disease through community promotions, including our Blue September campaign; funding research; and advocating for patients. More…
Latest News
While a number of prostate cancer patients in New Zealand are given MRI scans as part of their diagnostic process, this is limited by both the availability of the high quality technology required, particularly in regional centres, and the limited access to MRI scanners in the public health system. Clearly this new Guidance issued by…
Patron awarded Hercus Medal
The Prostate Cancer Foundation of NZ congratulates Patron Professor Brett Delahunt ONZM FRSNZ on being awarded the prestigious Hercus Medal by The Royal Society Te Apārangi. Professor Delahunt is a recognised international leader in the field of prostate cancer and is a strong advocate for awareness and better testing of men for prostate cancer. In…
Problems with an enlarged prostate
Not all prostate problems are caused by cancer. BPH (Benign Prostate Hyperplasia) is a far more common issue and typically causes problems with urination in men as they age. Professor Peter Gilling in Tauranga is an expert in this condition and has provided some helpful explanations and insights in this article at Health Central.
Prostate cancer later for Kiwi men
A University of Auckland research study shows that New Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific antigen (PSA) level and higher disease grade compared to men in the United States. The study was conducted by Dr Nishi Karunasinghe and colleagues at the Auckland Cancer Society Research Centre at the…
Men should be offered PSA test: new recommendation from U.S. authority
In a change of position, the U.S. Preventative Services Taskforce has reversed its earlier recommendation against PSA screening, to now recommend that men aged 55-69 make an individual decision about prostate cancer screening with their clinicians but recommends against routine screening for men age 70 and older. The new recommendation is based on new evidence that…
While a number of prostate cancer patients in New Zealand are given MRI scans as part of their diagnostic process, this is limited by both the availability of the high quality technology required, particularly in regional centres, and the limited access to MRI scanners in the public health system. Clearly this new Guidance issued by…
Patron awarded Hercus Medal
The Prostate Cancer Foundation of NZ congratulates Patron Professor Brett Delahunt ONZM FRSNZ on being awarded the prestigious Hercus Medal by The Royal Society Te Apārangi. Professor Delahunt is a recognised international leader in the field of prostate cancer and is a strong advocate for awareness and better testing of men for prostate cancer. In…
Problems with an enlarged prostate
Not all prostate problems are caused by cancer. BPH (Benign Prostate Hyperplasia) is a far more common issue and typically causes problems with urination in men as they age. Professor Peter Gilling in Tauranga is an expert in this condition and has provided some helpful explanations and insights in this article at Health Central.
Prostate cancer later for Kiwi men
A University of Auckland research study shows that New Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific antigen (PSA) level and higher disease grade compared to men in the United States. The study was conducted by Dr Nishi Karunasinghe and colleagues at the Auckland Cancer Society Research Centre at the…
Men should be offered PSA test: new recommendation from U.S. authority
In a change of position, the U.S. Preventative Services Taskforce has reversed its earlier recommendation against PSA screening, to now recommend that men aged 55-69 make an individual decision about prostate cancer screening with their clinicians but recommends against routine screening for men age 70 and older. The new recommendation is based on new evidence that…